| Year |
Citation |
Score |
| 2021 |
Yang J, Antin P, Berx G, Blanpain C, Brabletz T, Bronner M, Campbell K, Cano A, Casanova J, Christofori G, Dedhar S, Derynck R, Ford HL, Fuxe J, García de Herreros A, et al. Author Correction: Guidelines and definitions for research on epithelial-mesenchymal transition. Nature Reviews. Molecular Cell Biology. PMID 34654908 DOI: 10.1038/s41580-021-00428-9 |
0.368 |
|
| 2020 |
Valiente M, Van Swearingen AED, Anders CK, Bairoch A, Boire A, Bos PD, Cittelly DM, Erez N, Ferraro GB, Fukumura D, Gril B, Herlyn M, Holmen SL, Jain RK, Joyce JA, ... ... Massague J, et al. Brain Metastasis Cell Lines Panel: a public resource of organotropic cell lines. Cancer Research. PMID 32641416 DOI: 10.1158/0008-5472.Can-20-0291 |
0.681 |
|
| 2020 |
Yang J, Antin P, Berx G, Blanpain C, Brabletz T, Bronner M, Campbell K, Cano A, Casanova J, Christofori G, Dedhar S, Derynck R, Ford HL, Fuxe J, García de Herreros A, et al. Guidelines and definitions for research on epithelial-mesenchymal transition. Nature Reviews. Molecular Cell Biology. PMID 32300252 DOI: 10.1038/S41580-020-0237-9 |
0.492 |
|
| 2020 |
Laughney AM, Hu J, Campbell NR, Bakhoum SF, Setty M, Lavallée VP, Xie Y, Masilionis I, Carr AJ, Kottapalli S, Allaj V, Mattar M, Rekhtman N, Xavier JB, Mazutis L, et al. Regenerative lineages and immune-mediated pruning in lung cancer metastasis. Nature Medicine. PMID 32042191 DOI: 10.1038/S41591-019-0750-6 |
0.331 |
|
| 2020 |
Li AM, Ducker GS, Li Y, Seoane JA, Xiao Y, Melemenidis S, Zhou Y, Liu L, Vanharanta S, Graves EE, Rankin EB, Curtis C, Massague J, Rabinowitz JD, Thompson CB, et al. Metabolic Profiling Reveals a Dependency of Human Metastatic Breast Cancer on Mitochondrial Serine and One-Carbon Unit Metabolism. Molecular Cancer Research : McR. PMID 31941752 DOI: 10.1158/1541-7786.Mcr-19-0606 |
0.324 |
|
| 2020 |
Su J, Morgani SM, David CJ, Wang Q, Er EE, Huang YH, Basnet H, Zou Y, Shu W, Soni RK, Hendrickson RC, Hadjantonakis AK, Massagué J. TGF-β orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1. Nature. PMID 31915377 DOI: 10.1038/S41586-019-1897-5 |
0.399 |
|
| 2020 |
Ganesh K, Basnet H, Kaygusuz Y, Laughney A, He L, Sharma R, O'Rourke K, Reuter V, Huang Y, Masilionis I, Turkekul M, Er E, Manova-Todorova K, Saltz L, Weiser M, ... ... Massague J, et al. Abstract A12: L1CAM defines the regenerative origin of metastasis initiating cells in colorectal cancer Cancer Research. 80. DOI: 10.1158/1538-7445.Camodels2020-A12 |
0.36 |
|
| 2020 |
Li AM, Ducker GS, Li Y, Seoane JA, Xiao Y, Melemenidis S, Zhou Y, Liu L, Vanharanta S, Graves EE, Rankin EB, Curtis C, Massague J, Rabinowitz JD, Thompson CB, et al. Abstract 5713: Reprogramming of serine metabolism during breast cancer progression Cancer Research. 80: 5713-5713. DOI: 10.1158/1538-7445.Am2020-5713 |
0.365 |
|
| 2019 |
Aragón E, Wang Q, Zou Y, Morgani SM, Ruiz L, Kaczmarska Z, Su J, Torner C, Tian L, Hu J, Shu W, Agrawal S, Gomes T, Márquez JA, Hadjantonakis AK, et al. Structural basis for distinct roles of SMAD2 and SMAD3 in FOXH1 pioneer-directed TGF-β signaling. Genes & Development. PMID 31582430 DOI: 10.1101/Gad.330837.119 |
0.414 |
|
| 2019 |
Huang YH, Hu J, Chen F, Lecomte N, Basnet H, David CJ, Witkin MD, Allen PJ, Leach SD, Hollmann TJ, Iacobuzio-Donahue CA, Massague J. ID1 mediates escape from TGF-β tumor suppression in pancreatic cancer. Cancer Discovery. PMID 31582374 DOI: 10.1158/2159-8290.Cd-19-0529 |
0.396 |
|
| 2019 |
Luo M, Bai J, Liu B, Yan P, Zuo F, Sun H, Sun Y, Xu X, Song Z, Yang Y, Massagué J, Lan X, Lu Z, Chen YG, Deng H, et al. H3K18ac Primes Mesendodermal Differentiation upon Nodal Signaling. Stem Cell Reports. PMID 31564646 DOI: 10.1016/J.Stemcr.2019.08.016 |
0.385 |
|
| 2019 |
Batlle E, Massagué J. Transforming Growth Factor-β Signaling in Immunity and Cancer. Immunity. 50: 924-940. PMID 30995507 DOI: 10.1016/J.Immuni.2019.03.024 |
0.373 |
|
| 2018 |
Er EE, Valiente M, Ganesh K, Zou Y, Agrawal S, Hu J, Griscom B, Rosenblum M, Boire A, Brogi E, Giancotti FG, Schachner M, Malladi S, Massagué J. Pericyte-like spreading by disseminated cancer cells activates YAP and MRTF for metastatic colonization. Nature Cell Biology. PMID 30038252 DOI: 10.1038/S41556-018-0138-8 |
0.396 |
|
| 2018 |
Ganesh K, Massagué J. TGF-β Inhibition and Immunotherapy: Checkmate. Immunity. 48: 626-628. PMID 29669246 DOI: 10.1016/J.Immuni.2018.03.037 |
0.323 |
|
| 2018 |
David CJ, Massagué J. Contextual determinants of TGFβ action in development, immunity and cancer. Nature Reviews. Molecular Cell Biology. PMID 29643418 DOI: 10.1038/S41580-018-0007-0 |
0.41 |
|
| 2018 |
Xie XP, Laks DR, Sun D, Poran A, Laughney AM, Belenguer G, Massague J, Zhou X, Farinas I, Elemento O, Parada LF. Abstract 3015: Precise investigation of cancer stem cells in mouse glioblastoma Cancer Research. 78: 3015-3015. DOI: 10.1158/1538-7445.Am2018-3015 |
0.325 |
|
| 2017 |
Martin-Malpartida P, Batet M, Kaczmarska Z, Freier R, Gomes T, Aragón E, Zou Y, Wang Q, Xi Q, Ruiz L, Vea A, Márquez JA, Massagué J, Macias MJ. Structural basis for genome wide recognition of 5-bp GC motifs by SMAD transcription factors. Nature Communications. 8: 2070. PMID 29234012 DOI: 10.1038/S41467-017-02054-6 |
0.389 |
|
| 2017 |
Boire A, Zou Y, Shieh J, Macalinao DG, Pentsova E, Massagué J. Complement Component 3 Adapts the Cerebrospinal Fluid for Leptomeningeal Metastasis. Cell. 168: 1101-1113.e13. PMID 28283064 DOI: 10.1016/J.Cell.2017.02.025 |
0.358 |
|
| 2016 |
Wang Q, Zou Y, Nowotschin S, Kim SY, Li QV, Soh CL, Su J, Zhang C, Shu W, Xi Q, Huangfu D, Hadjantonakis AK, Massagué J. The p53 Family Coordinates Wnt and Nodal Inputs in Mesendodermal Differentiation of Embryonic Stem Cells. Cell Stem Cell. PMID 27889317 DOI: 10.1016/J.Stem.2016.10.002 |
0.33 |
|
| 2016 |
Chen Q, Boire A, Jin X, Valiente M, Er EE, Lopez-Soto A, Jacob LS, Patwa R, Shah H, Xu K, Cross JR, Massagué J. Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer. Nature. 533: 493-8. PMID 27225120 DOI: 10.1038/Nature18268 |
0.316 |
|
| 2016 |
Malladi S, Macalinao DG, Jin X, He L, Basnet H, Zou Y, de Stanchina E, Massagué J. Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT. Cell. 165: 45-60. PMID 27015306 DOI: 10.1016/J.Cell.2016.02.025 |
0.369 |
|
| 2016 |
David CJ, Huang YH, Chen M, Su J, Zou Y, Bardeesy N, Iacobuzio-Donahue CA, Massagué J. TGF-β Tumor Suppression through a Lethal EMT. Cell. PMID 26898331 DOI: 10.1016/J.Cell.2016.01.009 |
0.374 |
|
| 2016 |
Acharyya S, Massague J. Arresting supporters: targeting neutrophils in metastasis. Cell Research. 26: 273-4. PMID 26823207 DOI: 10.1038/Cr.2016.17 |
0.338 |
|
| 2016 |
Laughney AM, Malladi S, Macalinao D, Massagué J. Abstract A01: Investigating clonal heterogeneity and transcriptional vulnerabilities in latent metastasis Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Devbiolca15-A01 |
0.35 |
|
| 2016 |
Malladi S, Macalinao DG, Jin X, He L, Massague J. Abstract PR06: Metastatic latency and immune evasion mediated by autocrine WNT inhibition Cancer Research. 76. DOI: 10.1158/1538-7445.Tummet15-Pr06 |
0.371 |
|
| 2016 |
Massagué J. Abstract IA18: Latency and immune evasion of metastatic stem cells Cancer Research. 76. DOI: 10.1158/1538-7445.Tme16-Ia18 |
0.377 |
|
| 2016 |
Massague J. Abstract SY20-03: Metastatic latency and immune evasion by cancer stem cells Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Sy20-03 |
0.371 |
|
| 2015 |
Obenauf AC, Massagué J. Surviving at a Distance: Organ-Specific Metastasis. Trends in Cancer. 1: 76-91. PMID 28741564 DOI: 10.1016/J.Trecan.2015.07.009 |
0.315 |
|
| 2015 |
Macias MJ, Martin-Malpartida P, Massagué J. Structural determinants of Smad function in TGF-β signaling. Trends in Biochemical Sciences. 40: 296-308. PMID 25935112 DOI: 10.1016/J.Tibs.2015.03.012 |
0.365 |
|
| 2015 |
Obenauf AC, Zou Y, Ji AL, Vanharanta S, Shu W, Shi H, Kong X, Bosenberg MC, Wiesner T, Rosen N, Lo RS, Massagué J. Therapy-induced tumour secretomes promote resistance and tumour progression. Nature. 520: 368-72. PMID 25807485 DOI: 10.1038/Nature14336 |
0.311 |
|
| 2015 |
Sevenich L, Bowman R, Mason S, Quail D, Rapaport F, Elie B, Brogi E, Brastianos P, Hahn W, Holsinger L, Massagué J, Leslie C, Joyce JA. Abstract IA18: A brain metastasis-promoting role for cathepsin S identified from analysis of tumor- and stroma-supplied proteolytic networks Cancer Research. 75. DOI: 10.1158/1538-7445.Chtme14-Ia18 |
0.343 |
|
| 2015 |
Boire A, Zou Y, Jacob L, DeAngelis L, Massagué J. Bmet-03Solid Tumors Exploit Innate Immunity To Generate Leptomeningeal Metastases Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov208.03 |
0.356 |
|
| 2014 |
Vanharanta S, Marney CB, Shu W, Valiente M, Zou Y, Mele A, Darnell RB, Massagué J. Loss of the multifunctional RNA-binding protein RBM47 as a source of selectable metastatic traits in breast cancer. Elife. 3. PMID 24898756 DOI: 10.7554/Elife.02734 |
0.345 |
|
| 2014 |
Oskarsson T, Batlle E, Massagué J. Metastatic stem cells: sources, niches, and vital pathways. Cell Stem Cell. 14: 306-21. PMID 24607405 DOI: 10.1016/J.Stem.2014.02.002 |
0.355 |
|
| 2014 |
Boire A, Zou Y, DeAngelis L, Massagué J. Bm-06Mechanistic Investigations Of Leptomeningeal Metastasis From Solid Tumors. Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou240.6 |
0.33 |
|
| 2013 |
Stankic M, Pavlovic S, Chin Y, Brogi E, Padua D, Norton L, Massagué J, Benezra R. TGF-β-Id1 signaling opposes Twist1 and promotes metastatic colonization via a mesenchymal-to-epithelial transition. Cell Reports. 5: 1228-42. PMID 24332369 DOI: 10.1016/J.Celrep.2013.11.014 |
0.727 |
|
| 2013 |
Vanharanta S, Massagué J. Origins of metastatic traits. Cancer Cell. 24: 410-21. PMID 24135279 DOI: 10.1016/J.Ccr.2013.09.007 |
0.346 |
|
| 2013 |
Vanharanta S, Massagué J. Hypoxia signaling--license to metastasize. Cancer Discovery. 3: 1103-4. PMID 24124230 DOI: 10.1158/2159-8290.Cd-13-0481 |
0.324 |
|
| 2013 |
Zhang XH, Jin X, Malladi S, Zou Y, Wen YH, Brogi E, Smid M, Foekens JA, Massagué J. Selection of bone metastasis seeds by mesenchymal signals in the primary tumor stroma. Cell. 154: 1060-73. PMID 23993096 DOI: 10.1016/J.Cell.2013.07.036 |
0.383 |
|
| 2013 |
Vanharanta S, Shu W, Brenet F, Hakimi AA, Heguy A, Viale A, Reuter VE, Hsieh JJ, Scandura JM, Massagué J. Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer. Nature Medicine. 19: 50-6. PMID 23223005 DOI: 10.1038/Nm.3029 |
0.376 |
|
| 2013 |
Massagué J. Abstract IA13: Niches and pathways of latent and overt metastasis Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-Ia13 |
0.408 |
|
| 2013 |
Zhang X, Jin X, Malladi S, Wen Y, Brogi E, Massague J. Abstract C8: Bone metastasis seed preselection by the primary tumor stroma Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-C8 |
0.345 |
|
| 2013 |
Valiente M, Lee DJ, Obenauf A, Huse JT, Chaft JE, Kris MG, Brogi E, Massagué J. Abstract A29: Cooption of the reactive stroma by brain metastasis relies on protease inhibitors Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-A29 |
0.334 |
|
| 2013 |
Massagué J. Abstract IA25: Metastasis pathways Cancer Research. 73. DOI: 10.1158/1538-7445.Fbcr13-Ia25 |
0.4 |
|
| 2013 |
Acharyya S, Wojnarowicz P, Macalinao D, Khanin R, Granot Z, Benezra R, Massagué J. 1 Cytokine. 63: 243. DOI: 10.1016/J.Cyto.2013.06.004 |
0.381 |
|
| 2012 |
Calon A, Espinet E, Palomo-Ponce S, Tauriello DV, Iglesias M, Céspedes MV, Sevillano M, Nadal C, Jung P, Zhang XH, Byrom D, Riera A, Rossell D, Mangues R, Massagué J, et al. Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation. Cancer Cell. 22: 571-84. PMID 23153532 DOI: 10.1016/J.Ccr.2012.08.013 |
0.373 |
|
| 2012 |
Massagué J. TGFβ signalling in context. Nature Reviews. Molecular Cell Biology. 13: 616-30. PMID 22992590 DOI: 10.1038/Nrm3434 |
0.347 |
|
| 2012 |
Aragón E, Goerner N, Xi Q, Gomes T, Gao S, Massagué J, Macias MJ. Structural basis for the versatile interactions of Smad7 with regulator WW domains in TGF-β Pathways. Structure (London, England : 1993). 20: 1726-36. PMID 22921829 DOI: 10.1016/J.Str.2012.07.014 |
0.412 |
|
| 2012 |
Chen Q, Massagué J. Molecular pathways: VCAM-1 as a potential therapeutic target in metastasis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 5520-5. PMID 22879387 DOI: 10.1158/1078-0432.Ccr-11-2904 |
0.389 |
|
| 2012 |
Aggarwal K, Massagué J. Ubiquitin removal in the TGF-β pathway. Nature Cell Biology. 14: 656-7. PMID 22743709 DOI: 10.1038/Ncb2534 |
0.397 |
|
| 2012 |
Massagué J, Xi Q. TGF-β control of stem cell differentiation genes. Febs Letters. 586: 1953-8. PMID 22710171 DOI: 10.1016/J.Febslet.2012.03.023 |
0.372 |
|
| 2012 |
Huang J, Li YM, Massague J, Sicheneder A, Vallera DA, Hall WA. Intracerebral infusion of the bispecific targeted toxin DTATEGF in a mouse xenograft model of a human metastatic non-small cell lung cancer. Journal of Neuro-Oncology. 109: 229-38. PMID 22696210 DOI: 10.1007/S11060-012-0904-6 |
0.333 |
|
| 2012 |
Massagué J. TGF-β signaling in development and disease. Febs Letters. 586: 1833. PMID 22651913 DOI: 10.1016/J.Febslet.2012.05.030 |
0.328 |
|
| 2012 |
Oskarsson T, Massagué J. Extracellular matrix players in metastatic niches. The Embo Journal. 31: 254-6. PMID 22179697 DOI: 10.1038/Emboj.2011.469 |
0.349 |
|
| 2012 |
Acharyya S, Oskarsson T, Vanharanta S, Malladi S, Kim J, Brogi E, Norton L, Massague J. Abstract B40: Paracrine interactions through CXCL1/2 chemokines promote breast cancer metastasis and chemoresistance Clinical Cancer Research. 18: B40-B40. DOI: 10.1158/1078-0432.Mechres-B40 |
0.369 |
|
| 2011 |
Lu X, Mu E, Wei Y, Riethdorf S, Yang Q, Yuan M, Yan J, Hua Y, Tiede BJ, Lu X, Haffty BG, Pantel K, Massagué J, Kang Y. VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors. Cancer Cell. 20: 701-14. PMID 22137794 DOI: 10.1016/J.Ccr.2011.11.002 |
0.529 |
|
| 2011 |
Chen Q, Zhang XH, Massagué J. Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs. Cancer Cell. 20: 538-49. PMID 22014578 DOI: 10.1016/J.Ccr.2011.08.025 |
0.381 |
|
| 2011 |
Gucalp A, Sparano JA, Caravelli J, Santamauro J, Patil S, Abbruzzi A, Pellegrino C, Bromberg J, Dang C, Theodoulou M, Massague J, Norton L, Hudis C, Traina TA. Phase II trial of saracatinib (AZD0530), an oral SRC-inhibitor for the treatment of patients with hormone receptor-negative metastatic breast cancer. Clinical Breast Cancer. 11: 306-11. PMID 21729667 DOI: 10.1016/J.Clbc.2011.03.021 |
0.304 |
|
| 2011 |
Aragón E, Goerner N, Zaromytidou AI, Xi Q, Escobedo A, Massagué J, Macias MJ. A Smad action turnover switch operated by WW domain readers of a phosphoserine code. Genes & Development. 25: 1275-88. PMID 21685363 DOI: 10.1101/Gad.2060811 |
0.376 |
|
| 2011 |
Comen E, Norton L, Massagué J. Clinical implications of cancer self-seeding. Nature Reviews. Clinical Oncology. 8: 369-77. PMID 21522121 DOI: 10.1038/Nrclinonc.2011.64 |
0.305 |
|
| 2011 |
Fang F, Turcan S, Rimner A, Kaufman A, Giri D, Morris LG, Shen R, Seshan V, Mo Q, Heguy A, Baylin SB, Ahuja N, Viale A, Massague J, Norton L, et al. Breast cancer methylomes establish an epigenomic foundation for metastasis. Science Translational Medicine. 3: 75ra25. PMID 21430268 DOI: 10.1126/Scitranslmed.3001875 |
0.306 |
|
| 2011 |
Schultz N, Marenstein DR, De Angelis DA, Wang WQ, Nelander S, Jacobsen A, Marks DS, Massagué J, Sander C. Off-target effects dominate a large-scale RNAi screen for modulators of the TGF-β pathway and reveal microRNA regulation of TGFBR2. Silence. 2: 3. PMID 21401928 DOI: 10.1186/1758-907X-2-3 |
0.319 |
|
| 2011 |
Dorn DC, He W, Massague J, Moore MAS. TIF1γ Knockdown Enhances Hematopoietic Stem Cell Self Renewal with Preferential Myeloid Differentiation and Delayed Erythropoiesis Blood. 118: 4829-4829. DOI: 10.1182/Blood.V118.21.4829.4829 |
0.338 |
|
| 2011 |
Sevenich L, Mason S, Rapaport F, Massague J, Leslie C, Joyce J. Abstract 2844: Systems biology analysis of tumor and stromal genes in different metastatic microenvironments Cancer Research. 71: 2844-2844. DOI: 10.1158/1538-7445.Am2011-2844 |
0.342 |
|
| 2010 |
Arnal-Estapé A, Tarragona M, Morales M, Guiu M, Nadal C, Massagué J, Gomis RR. HER2 silences tumor suppression in breast cancer cells by switching expression of C/EBPß isoforms. Cancer Research. 70: 9927-36. PMID 21098707 DOI: 10.1158/0008-5472.Can-10-0869 |
0.405 |
|
| 2010 |
Bos PD, Nguyen DX, Massagué J. Modeling metastasis in the mouse. Current Opinion in Pharmacology. 10: 571-7. PMID 20598638 DOI: 10.1016/J.Coph.2010.06.003 |
0.688 |
|
| 2010 |
Oskarsson T, Nagorny P, Krauss IJ, Perez L, Mandal M, Yang G, Ouerfelli O, Xiao D, Moore MA, Massagué J, Danishefsky SJ. Diverted total synthesis leads to the generation of promising cell-migration inhibitors for treatment of tumor metastasis: in vivo and mechanistic studies on the migrastatin core ether analog. Journal of the American Chemical Society. 132: 3224-8. PMID 20155906 DOI: 10.1021/Ja9101503 |
0.325 |
|
| 2010 |
Lu X, Yang Q, Yuan M, Mu E, Reiss M, Haffty B, Massagué J, Kang Y. Abstract 5763: VCAM1 mediates aggressive bone metastasis outbreak from tumor dormancy by engaging α4β1-positive osteoclast progenitor cells Cancer Research. 70: 5763-5763. DOI: 10.1158/1538-7445.Am10-5763 |
0.533 |
|
| 2009 |
Kim MY, Oskarsson T, Acharyya S, Nguyen DX, Zhang XH, Norton L, Massagué J. Tumor self-seeding by circulating cancer cells. Cell. 139: 1315-26. PMID 20064377 DOI: 10.1016/J.Cell.2009.11.025 |
0.307 |
|
| 2009 |
Gao S, Alarcón C, Sapkota G, Rahman S, Chen PY, Goerner N, Macias MJ, Erdjument-Bromage H, Tempst P, Massagué J. Ubiquitin ligase Nedd4L targets activated Smad2/3 to limit TGF-beta signaling. Molecular Cell. 36: 457-68. PMID 19917253 DOI: 10.1016/J.Molcel.2009.09.043 |
0.791 |
|
| 2009 |
Lu X, Wang Q, Hu G, Van Poznak C, Fleisher M, Reiss M, Massagué J, Kang Y. ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis. Genes & Development. 23: 1882-94. PMID 19608765 DOI: 10.1101/Gad.1824809 |
0.552 |
|
| 2009 |
Zhang XH, Wang Q, Gerald W, Hudis CA, Norton L, Smid M, Foekens JA, Massagué J. Latent bone metastasis in breast cancer tied to Src-dependent survival signals. Cancer Cell. 16: 67-78. PMID 19573813 DOI: 10.1016/J.Ccr.2009.05.017 |
0.365 |
|
| 2009 |
Bos PD, Zhang XH, Nadal C, Shu W, Gomis RR, Nguyen DX, Minn AJ, van de Vijver MJ, Gerald WL, Foekens JA, Massagué J. Genes that mediate breast cancer metastasis to the brain. Nature. 459: 1005-9. PMID 19421193 DOI: 10.1038/Nature08021 |
0.698 |
|
| 2009 |
Nguyen DX, Bos PD, Massagué J. Metastasis: from dissemination to organ-specific colonization. Nature Reviews. Cancer. 9: 274-84. PMID 19308067 DOI: 10.1038/Nrc2622 |
0.685 |
|
| 2009 |
Padua D, Massagué J. Roles of TGFbeta in metastasis. Cell Research. 19: 89-102. PMID 19050696 DOI: 10.1038/Cr.2008.316 |
0.716 |
|
| 2009 |
Massagué J. Abstract IA-19: Deconstructing metastasis Cancer Research. 69. DOI: 10.1158/0008-5472.Fbcr09-Ia-19 |
0.368 |
|
| 2008 |
Massagué J. TGFbeta in Cancer. Cell. 134: 215-30. PMID 18662538 DOI: 10.1016/J.Cell.2008.07.001 |
0.406 |
|
| 2008 |
Padua D, Zhang XH, Wang Q, Nadal C, Gerald WL, Gomis RR, Massagué J. TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell. 133: 66-77. PMID 18394990 DOI: 10.1016/J.Cell.2008.01.046 |
0.707 |
|
| 2008 |
Massagué J. A very private TGF-beta receptor embrace. Molecular Cell. 29: 149-50. PMID 18243107 DOI: 10.1016/J.Molcel.2008.01.006 |
0.392 |
|
| 2008 |
Xi Q, He W, Zhang XH, Le HV, Massagué J. Genome-wide impact of the BRG1 SWI/SNF chromatin remodeler on the transforming growth factor beta transcriptional program. The Journal of Biological Chemistry. 283: 1146-55. PMID 18003620 DOI: 10.1074/Jbc.M707479200 |
0.38 |
|
| 2008 |
Siegel PM, Massagué J. 11 Growth Control by TGF-β: Mechanisms Controlling Cell Cycle Progression and Apoptosis Cold Spring Harbor Monograph Archive. 50: 333-362. DOI: 10.1101/087969752.50.333 |
0.378 |
|
| 2007 |
Gupta GP, Perk J, Acharyya S, de Candia P, Mittal V, Todorova-Manova K, Gerald WL, Brogi E, Benezra R, Massagué J. ID genes mediate tumor reinitiation during breast cancer lung metastasis. Proceedings of the National Academy of Sciences of the United States of America. 104: 19506-11. PMID 18048329 DOI: 10.1073/Pnas.0709185104 |
0.651 |
|
| 2007 |
Nguyen DX, Massagué J. Genetic determinants of cancer metastasis. Nature Reviews. Genetics. 8: 341-52. PMID 17440531 DOI: 10.1038/Nrg2101 |
0.321 |
|
| 2007 |
Minn AJ, Gupta GP, Padua D, Bos P, Nguyen DX, Nuyten D, Kreike B, Zhang Y, Wang Y, Ishwaran H, Foekens JA, van de Vijver M, Massagué J. Lung metastasis genes couple breast tumor size and metastatic spread. Proceedings of the National Academy of Sciences of the United States of America. 104: 6740-5. PMID 17420468 DOI: 10.1073/Pnas.0701138104 |
0.773 |
|
| 2007 |
Sapkota G, Alarcón C, Spagnoli FM, Brivanlou AH, Massagué J. Balancing BMP signaling through integrated inputs into the Smad1 linker. Molecular Cell. 25: 441-54. PMID 17289590 DOI: 10.1016/J.Molcel.2007.01.006 |
0.791 |
|
| 2007 |
Massagué J. Sorting out breast-cancer gene signatures. The New England Journal of Medicine. 356: 294-7. PMID 17229957 DOI: 10.1056/Nejme068292 |
0.315 |
|
| 2007 |
Li F, Tiede B, Massagué J, Kang Y. Beyond tumorigenesis: cancer stem cells in metastasis. Cell Research. 17: 3-14. PMID 17179981 DOI: 10.1038/Sj.Cr.7310118 |
0.534 |
|
| 2006 |
Gupta GP, Massagué J. Cancer metastasis: building a framework. Cell. 127: 679-95. PMID 17110329 DOI: 10.1016/J.Cell.2006.11.001 |
0.623 |
|
| 2006 |
Sapkota G, Knockaert M, Alarcón C, Montalvo E, Brivanlou AH, Massagué J. Dephosphorylation of the linker regions of Smad1 and Smad2/3 by small C-terminal domain phosphatases has distinct outcomes for bone morphogenetic protein and transforming growth factor-beta pathways. The Journal of Biological Chemistry. 281: 40412-9. PMID 17085434 DOI: 10.1074/Jbc.M610172200 |
0.793 |
|
| 2006 |
Gomis RR, Alarcón C, Nadal C, Van Poznak C, Massagué J. C/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells. Cancer Cell. 10: 203-14. PMID 16959612 DOI: 10.1016/J.Ccr.2006.07.019 |
0.771 |
|
| 2006 |
Norton L, Massagué J. Is cancer a disease of self-seeding? Nature Medicine. 12: 875-8. PMID 16892025 DOI: 10.1038/Nm0806-875 |
0.307 |
|
| 2006 |
Knockaert M, Sapkota G, Alarcón C, Massagué J, Brivanlou AH. Unique players in the BMP pathway: small C-terminal domain phosphatases dephosphorylate Smad1 to attenuate BMP signaling. Proceedings of the National Academy of Sciences of the United States of America. 103: 11940-5. PMID 16882717 DOI: 10.1073/Pnas.0605133103 |
0.804 |
|
| 2006 |
He W, Dorn DC, Erdjument-Bromage H, Tempst P, Moore MA, Massagué J. Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. Cell. 125: 929-41. PMID 16751102 DOI: 10.1016/J.Cell.2006.03.045 |
0.433 |
|
| 2006 |
Massagué J, Gomis RR. The logic of TGFbeta signaling. Febs Letters. 580: 2811-20. PMID 16678165 DOI: 10.1016/J.Febslet.2006.04.033 |
0.395 |
|
| 2006 |
Kang Y, He W, Tulley S, Gupta GP, Serganova I, Chen CR, Manova-Todorova K, Blasberg R, Gerald WL, Massagué J. Erratum: Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway (Proceedings of the National Academy of Sciences of the United States of America) (September 27, 2005) 102 (13909-13914) DOI: 10.1073/pnas.0506517102)) Proceedings of the National Academy of Sciences of the United States of America. 103. DOI: 10.1073/Pnas.0603221103 |
0.526 |
|
| 2005 |
Massagué J, Seoane J, Wotton D. Smad transcription factors. Genes & Development. 19: 2783-810. PMID 16322555 DOI: 10.1101/Gad.1350705 |
0.388 |
|
| 2005 |
Thomas DA, Massagué J. TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. Cancer Cell. 8: 369-80. PMID 16286245 DOI: 10.1016/J.Ccr.2005.10.012 |
0.401 |
|
| 2005 |
Kang Y, He W, Tulley S, Gupta GP, Serganova I, Chen CR, Manova-Todorova K, Blasberg R, Gerald WL, Massagué J. Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway. Proceedings of the National Academy of Sciences of the United States of America. 102: 13909-14. PMID 16172383 DOI: 10.1073/Pnas.0506517102 |
0.725 |
|
| 2005 |
Minn AJ, Kang Y, Serganova I, Gupta GP, Giri DD, Doubrovin M, Ponomarev V, Gerald WL, Blasberg R, Massagué J. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. The Journal of Clinical Investigation. 115: 44-55. PMID 15630443 DOI: 10.1172/Jci22320 |
0.696 |
|
| 2004 |
Gupta GP, Massagué J. Platelets and metastasis revisited: a novel fatty link. The Journal of Clinical Investigation. 114: 1691-3. PMID 15599391 DOI: 10.1172/JCI23823 |
0.581 |
|
| 2004 |
Massagué J. G1 cell-cycle control and cancer. Nature. 432: 298-306. PMID 15549091 DOI: 10.1038/Nature03094 |
0.324 |
|
| 2004 |
Scandura JM, Boccuni P, Massagué J, Nimer SD. Transforming growth factor beta-induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation. Proceedings of the National Academy of Sciences of the United States of America. 101: 15231-6. PMID 15477587 DOI: 10.1073/Pnas.0406771101 |
0.363 |
|
| 2004 |
Kang Y, Massagué J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell. 118: 277-9. PMID 15294153 DOI: 10.1016/J.Cell.2004.07.011 |
0.538 |
|
| 2004 |
Calonge MJ, Seoane J, Massagué J. Opposite Smad and chicken ovalbumin upstream promoter transcription factor inputs in the regulation of the collagen VII gene promoter by transforming growth factor-beta. The Journal of Biological Chemistry. 279: 23759-65. PMID 15047696 DOI: 10.1074/Jbc.M402178200 |
0.408 |
|
| 2004 |
Xu L, Massagué J. Nucleocytoplasmic shuttling of signal transducers. Nature Reviews. Molecular Cell Biology. 5: 209-19. PMID 14991001 DOI: 10.1038/Nrm1331 |
0.324 |
|
| 2004 |
Massagué J, Attisano L, Wrana JL. The TGF-beta family and its composite receptors. Trends in Cell Biology. 4: 172-8. PMID 14731645 DOI: 10.1016/0962-8924(94)90202-X |
0.745 |
|
| 2004 |
Gupta GP, Massagué J. Platelets and metastasis revisited: a novel fatty link Journal of Clinical Investigation. 114: 1691-1693. DOI: 10.1172/Jci200423823 |
0.328 |
|
| 2004 |
Scandura JM, Boccuni P, Massagué J, Nimer SD. Erratum: Transforming growth factor β-induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation (Proceedings of the National Academy of Sciences of the United States of America (October 19, 2004) 101, 42 (15231-15236)) Proceedings of the National Academy of Sciences of the United States of America. 101. DOI: 10.1073/Pnas.0407769101 |
0.338 |
|
| 2003 |
Massague J. Integration of Smad and MAPK pathways: a link and a linker revisited. Genes & Development. 17: 2993-7. PMID 14701870 DOI: 10.1101/Gad.1167003 |
0.349 |
|
| 2003 |
Foletta VC, Lim MA, Soosairajah J, Kelly AP, Stanley EG, Shannon M, He W, Das S, Massague J, Bernard O, Soosairaiah J. Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1. The Journal of Cell Biology. 162: 1089-98. PMID 12963706 DOI: 10.1083/Jcb.200212060 |
0.382 |
|
| 2003 |
Xu L, Alarcón C, Cöl S, Massagué J. Distinct domain utilization by Smad3 and Smad4 for nucleoporin interaction and nuclear import. The Journal of Biological Chemistry. 278: 42569-77. PMID 12917407 DOI: 10.1074/Jbc.M307601200 |
0.787 |
|
| 2003 |
Shi Y, Massagué J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 113: 685-700. PMID 12809600 DOI: 10.1016/S0092-8674(03)00432-X |
0.437 |
|
| 2003 |
Kang Y, Chen CR, Massagué J. A self-enabling TGFbeta response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Molecular Cell. 11: 915-26. PMID 12718878 DOI: 10.1016/S1097-2765(03)00109-6 |
0.532 |
|
| 2003 |
Chai J, Wu JW, Yan N, Massagué J, Pavletich NP, Shi Y. Features of a Smad3 MH1-DNA complex: Roles of water and zinc in DNA binding Journal of Biological Chemistry. 278: 20327-20331. PMID 12686552 DOI: 10.1074/Jbc.C300134200 |
0.31 |
|
| 2002 |
Blain SW, Massagué J. Breast cancer banishes p27 from nucleus. Nature Medicine. 8: 1076-8. PMID 12357238 DOI: 10.1038/Nm1002-1076 |
0.305 |
|
| 2002 |
Xu L, Kang Y, Cöl S, Massagué J. Smad2 nucleocytoplasmic shuttling by nucleoporins CAN/Nup214 and Nup153 feeds TGFbeta signaling complexes in the cytoplasm and nucleus. Molecular Cell. 10: 271-82. PMID 12191473 DOI: 10.1016/S1097-2765(02)00586-5 |
0.571 |
|
| 2002 |
López-Rovira T, Chalaux E, Massagué J, Rosa JL, Ventura F. Direct binding of Smad1 and Smad4 to two distinct motifs mediates bone morphogenetic protein-specific transcriptional activation of Id1 gene. The Journal of Biological Chemistry. 277: 3176-85. PMID 11700304 DOI: 10.1074/Jbc.M106826200 |
0.36 |
|
| 2001 |
Wu JW, Hu M, Chai J, Seoane J, Huse M, Li C, Rigotti DJ, Kyin S, Muir TW, Fairman R, Massagué J, Shi Y. Crystal structure of a phosphorylated Smad2. Recognition of phosphoserine by the MH2 domain and insights on Smad function in TGF-beta signaling. Molecular Cell. 8: 1277-89. PMID 11779503 DOI: 10.1016/S1097-2765(01)00421-X |
0.428 |
|
| 2001 |
Huse M, Muir TW, Xu L, Chen YG, Kuriyan J, Massagué J. The TGF beta receptor activation process: an inhibitor- to substrate-binding switch. Molecular Cell. 8: 671-82. PMID 11583628 DOI: 10.1016/S1097-2765(01)00332-X |
0.378 |
|
| 2001 |
Seoane J, Pouponnot C, Staller P, Schader M, Eilers M, Massagué J. TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b. Nature Cell Biology. 3: 400-8. PMID 11283614 DOI: 10.1038/35070086 |
0.416 |
|
| 2001 |
Staller P, Peukert K, Kiermaier A, Seoane J, Lukas J, Karsunky H, Möröy T, Bartek J, Massagué J, Hänel F, Eilers M. Repression of p15INK4b expression by Myc through association with Miz-1. Nature Cell Biology. 3: 392-9. PMID 11283613 DOI: 10.1038/35070076 |
0.336 |
|
| 2001 |
Lo RS, Wotton D, Massagué J. Epidermal growth factor signaling via Ras controls the Smad transcriptional co-repressor TGIF Embo Journal. 20: 128-136. PMID 11226163 DOI: 10.1093/Emboj/20.1.128 |
0.408 |
|
| 2001 |
Chen CR, Kang Y, Massagué J. Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor β growth arrest program Proceedings of the National Academy of Sciences of the United States of America. 98: 992-999. PMID 11158583 DOI: 10.1073/Pnas.98.3.992 |
0.587 |
|
| 2000 |
Serrano M, Massagué J. Networks of tumor suppressors Embo Reports. 1: 115-119. PMID 11265748 DOI: 10.1093/Embo-Reports/Kvd034 |
0.338 |
|
| 2000 |
Massagué J. How cells read TGF-beta signals. Nature Reviews Molecular Cell Biology. 1: 169-178. PMID 11252892 DOI: 10.1038/35043051 |
0.405 |
|
| 2000 |
Jakubowiak A, Pouponnot C, Berguido F, Frank R, Mao S, Massagué J, Nimer SD. Inhibition of the Transforming Growth Factor β1 Signaling Pathway by the AML1/ETO Leukemia-associated Fusion Protein Journal of Biological Chemistry. 275: 40282-40287. PMID 11032826 DOI: 10.1074/Jbc.C000485200 |
0.392 |
|
| 2000 |
Jayaraman L, Massagué J. Distinct oligomeric states of SMAD proteins in the transforming growth factor-beta pathway. Journal of Biological Chemistry. 275: 40710-40717. PMID 11018029 DOI: 10.1074/Jbc.M005799200 |
0.411 |
|
| 2000 |
Dou C, Lee J, Liu B, Liu F, Massague J, Xuan S, Lai E. BF-1 Interferes with Transforming Growth Factor β Signaling by Associating with Smad Partners Molecular and Cellular Biology. 20: 6201-6211. PMID 10938097 DOI: 10.1128/Mcb.20.17.6201-6211.2000 |
0.391 |
|
| 2000 |
Blain SW, Massagué J. Different Sensitivity of the Transforming Growth Factor-β Cell Cycle Arrest Pathway to c-Myc and MDM-2 Journal of Biological Chemistry. 275: 32066-32070. PMID 10906337 DOI: 10.1074/Jbc.M006496200 |
0.375 |
|
| 2000 |
Gouédard L, Chen Y, Thevenet L, Racine C, Borie S, Lamarre I, Josso N, Massagué J, Clemente Nd. Engagement of bone morphogenetic protein type IB receptor and Smad1 signaling by anti-Müllerian hormone and its type II receptor. Journal of Biological Chemistry. 275: 27973-27978. PMID 10854429 DOI: 10.1074/Jbc.M002704200 |
0.366 |
|
| 2000 |
Gripp KW, Wotton D, Edwards MC, Roessler E, Ades L, Meinecke P, Richieri-Costa A, Zackai EH, Massagué J, Muenke M, Elledge SJ. Mutations in TGIF cause holoprosencephaly and link NODAL signalling to human neural axis determination Nature Genetics. 25: 205-208. PMID 10835638 DOI: 10.1038/76074 |
0.363 |
|
| 2000 |
Massagué J, Wotton D. Transcriptional control by the TGF-β/Smad signaling system Embo Journal. 19: 1745-1754. PMID 10775259 DOI: 10.1093/Emboj/19.8.1745 |
0.361 |
|
| 2000 |
Hata A, Seoane J, Lagna G, Montalvo E, Hemmati-Brivanlou A, Massagué J. OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways. Cell. 100: 229-40. PMID 10660046 DOI: 10.1016/S0092-8674(00)81561-5 |
0.721 |
|
| 2000 |
Massagué J, Chen Y. Controlling TGF-β signaling Genes & Development. 14: 627-644. DOI: 10.1101/Gad.14.6.627 |
0.334 |
|
| 1999 |
Wotton D, Lo RS, Swaby LAC, Massagué J. Multiple modes of repression by the Smad transcriptional corepressor TGIF Journal of Biological Chemistry. 274: 37105-37110. PMID 10601270 DOI: 10.1074/Jbc.274.52.37105 |
0.315 |
|
| 1999 |
Lo RS, Massagué J. Ubiquitin-dependent degradation of TGF-β-activated Smad2 Nature Cell Biology. 1: 472-478. PMID 10587642 DOI: 10.1038/70258 |
0.392 |
|
| 1999 |
Calonge MJ, Massagué J. Smad4/DPC4 silencing and hyperactive Ras jointly disrupt transforming growth factor-beta antiproliferative responses in colon cancer cells. Journal of Biological Chemistry. 274: 33637-33643. PMID 10559252 DOI: 10.1074/Jbc.274.47.33637 |
0.442 |
|
| 1999 |
Onichtchouk D, Chen YG, Dosch R, Gawantka V, Delius H, Massagué J, Niehrs C. Silencing of TGF-beta signalling by the pseudoreceptor BAMBI. Nature. 401: 480-485. PMID 10519551 DOI: 10.1038/46794 |
0.448 |
|
| 1999 |
Warner BJ, Blain SW, Seoane J, Massagué J. Myc Downregulation by Transforming Growth Factor β Required for Activation of the p15Ink4b G1 Arrest Pathway Molecular and Cellular Biology. 19: 5913-5922. PMID 10454538 DOI: 10.1128/Mcb.19.9.5913 |
0.379 |
|
| 1999 |
Wotton D, Lo RS, Lee S, Massagué J. A Smad transcriptional corepressor Cell. 97: 29-39. PMID 10199400 DOI: 10.1016/S0092-8674(00)80712-6 |
0.345 |
|
| 1999 |
Kretzschmar M, Doody J, Timokhina I, Massagué J. A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras. Genes & Development. 13: 804-816. PMID 10197981 DOI: 10.1101/Gad.13.7.804 |
0.34 |
|
| 1999 |
Ulloa L, Doody J, Massagué J. Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway. Nature. 397: 710-713. PMID 10067896 DOI: 10.1038/17826 |
0.429 |
|
| 1999 |
Huse M, Chen YG, Massagué J, Kuriyan J. Crystal structure of the cytoplasmic domain of the type I TGF beta receptor in complex with FKBP12. Cell. 96: 425-36. PMID 10025408 DOI: 10.1016/S0092-8674(00)80555-3 |
0.375 |
|
| 1999 |
Chen Y, Massagué J. Smad1 Recognition and Activation by the ALK1 Group of Transforming Growth Factor-β Family Receptors Journal of Biological Chemistry. 274: 3672-3677. PMID 9920917 DOI: 10.1074/Jbc.274.6.3672 |
0.382 |
|
| 1999 |
Yin JJ, Selander K, Chirgwin JM, Dallas M, Grubbs BG, Wieser R, Massagué J, Mundy GR, Guise TA. TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. The Journal of Clinical Investigation. 103: 197-206. PMID 9916131 DOI: 10.1172/Jci3523 |
0.456 |
|
| 1999 |
Iavarone A, Massagué J. E2F and Histone Deacetylase Mediate Transforming Growth Factor β Repression of cdc25A during Keratinocyte Cell Cycle Arrest Molecular and Cellular Biology. 19: 916-922. PMID 9858615 DOI: 10.1128/Mcb.19.1.916 |
0.416 |
|
| 1998 |
Massagué J. TGF-beta signal transduction. Annual Review of Biochemistry. 67: 753-91. PMID 9759503 DOI: 10.1146/ANNUREV.BIOCHEM.67.1.753 |
0.347 |
|
| 1998 |
Shi Y, Wang YF, Jayaraman L, Yang H, Massagué J, Pavletich NP. Crystal structure of a Smad MH1 domain bound to DNA: Insights on DNA binding in TGF-β signaling Cell. 94: 585-594. PMID 9741623 DOI: 10.1016/S0092-8674(00)81600-1 |
0.378 |
|
| 1998 |
Pouponnot C, Jayaraman L, Massagué J. Physical and Functional Interaction of SMADs and p300/CBP Journal of Biological Chemistry. 273: 22865-22868. PMID 9722503 DOI: 10.1074/Jbc.273.36.22865 |
0.38 |
|
| 1998 |
Hata A, Shi Y, Massagué J. TGF-beta signaling and cancer: structural and functional consequences of mutations in Smads. Molecular Medicine Today. 4: 257-62. PMID 9679244 DOI: 10.1016/S1357-4310(98)01247-7 |
0.434 |
|
| 1998 |
Chen YG, Hata A, Lo RS, Wotton D, Shi Y, Pavletich N, Massagué J. Determinants of specificity in TGF-β signal transduction Genes and Development. 12: 2144-2152. PMID 9679059 DOI: 10.1101/Gad.12.14.2144 |
0.459 |
|
| 1998 |
Kretzschmar M, Massagué J. SMADs: mediators and regulators of TGF-β signaling Current Opinion in Genetics & Development. 8: 103-111. PMID 9529613 DOI: 10.1016/S0959-437X(98)80069-5 |
0.446 |
|
| 1998 |
Lo RS, Chen YG, Shi Y, Pavletich NP, Massagué J. The L3 loop: A structural motif determining specific interactions between SMAD proteins and TGF-β receptors Embo Journal. 17: 996-1005. PMID 9463378 DOI: 10.1093/Emboj/17.4.996 |
0.441 |
|
| 1998 |
Hata A, Lagna G, Massagué J, Hemmati-Brivanlou A. Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor Genes & Development. 12: 186-197. PMID 9436979 DOI: 10.1101/Gad.12.2.186 |
0.698 |
|
| 1997 |
Chen Y, Liu F, Massagué J. Mechanism of TGFbeta receptor inhibition by FKBP12. The Embo Journal. 16: 3866-3876. PMID 9233797 DOI: 10.1093/Emboj/16.13.3866 |
0.391 |
|
| 1997 |
Shi Y, Hata A, Lo RS, Massagué J, Pavletich NP. A structural basis for mutational inactivation of the tumour suppressor Smad4 Nature. 388: 87-93. PMID 9214508 DOI: 10.1038/40431 |
0.415 |
|
| 1997 |
Hata A, Lo RS, Wotton D, Lagna G, Massagué J. Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4 Nature. 388: 82-87. PMID 9214507 DOI: 10.1038/40424 |
0.714 |
|
| 1997 |
lavarone A, Massagué J. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-β in cells lacking the CDK inhibitor p15 Nature. 387: 417-422. PMID 9163429 DOI: 10.1038/387417A0 |
0.372 |
|
| 1997 |
Kretzschmar M, Liu F, Hata A, Doody J, Massagué J. The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. Genes & Development. 11: 984-995. PMID 9136927 DOI: 10.1101/Gad.11.8.984 |
0.459 |
|
| 1997 |
Luo Y, Marx SO, Kiyokawa H, Koff A, Massagué J, Marks AR. Rapamycin resistance tied to defective regulation of p27Kip1. Molecular and Cellular Biology. 16: 6744-51. PMID 8943329 DOI: 10.1128/Mcb.16.12.6744 |
0.348 |
|
| 1996 |
Lagna G, Hata A, Hemmati-Brivanlou A, Massagué J. Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways. Nature. 383: 832-6. PMID 8893010 DOI: 10.1038/383832A0 |
0.463 |
|
| 1996 |
Massagué J. TGFβ Signaling: Receptors, Transducers, and Mad Proteins Cell. 85: 947-950. PMID 8674122 DOI: 10.1016/S0092-8674(00)81296-9 |
0.325 |
|
| 1996 |
Ventura F, Liu F, Doody J, Massagué J. Interaction of Transforming Growth Factor-β Receptor I with Farnesyl-protein Transferase-α in Yeast and Mammalian Cells Journal of Biological Chemistry. 271: 13931-13934. PMID 8663177 DOI: 10.1074/Jbc.271.24.13931 |
0.388 |
|
| 1996 |
Liu F, Hata A, Baker JC, Doody J, Cárcamo J, Harland RM, Massagué J. A human Mad protein acting as a BMP-regulated transcriptional activator. Nature. 381: 620-3. PMID 8637600 DOI: 10.1038/381620A0 |
0.451 |
|
| 1996 |
Arribas J, Coodly L, Vollmer P, Kishimoto TK, Rose-John S, Massagué J. Diverse Cell Surface Protein Ectodomains Are Shed by a System Sensitive to Metalloprotease Inhibitors Journal of Biological Chemistry. 271: 11376-11382. PMID 8626692 DOI: 10.1074/Jbc.271.19.11376 |
0.354 |
|
| 1996 |
Attisano L, Wrana JL, Montalvo E, Massagué J. Activation of signalling by the activin receptor complex. Molecular and Cellular Biology. 16: 1066-73. PMID 8622651 DOI: 10.1128/Mcb.16.3.1066 |
0.726 |
|
| 1996 |
Weis-Garcia F, Massagué J. Complementation between kinase-defective and activation-defective TGF-beta receptors reveals a novel form of receptor cooperativity essential for signaling. The Embo Journal. 15: 276-289. DOI: 10.1002/J.1460-2075.1996.Tb00358.X |
0.363 |
|
| 1995 |
Cárcamo J, Zentella A, Massagué J. Disruption of transforming growth factor beta signaling by a mutation that prevents transphosphorylation within the receptor complex. Molecular and Cellular Biology. 15: 1573-1581. PMID 7862150 DOI: 10.1128/Mcb.15.3.1573 |
0.374 |
|
| 1995 |
Arribas J, Massagué J. Transforming growth factor-alpha and beta-amyloid precursor protein share a secretory mechanism. Journal of Cell Biology. 128: 433-441. PMID 7844156 DOI: 10.1083/Jcb.128.3.433 |
0.359 |
|
| 1995 |
Liu F, Ventura F, Doody J, Massague J. Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs. Molecular and Cellular Biology. 15: 3479-3486. PMID 7791754 DOI: 10.1128/Mcb.15.7.3479 |
0.408 |
|
| 1995 |
Luo Y, Hurwitz J, Massagué J. Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1. Nature. 375: 159-61. PMID 7753174 DOI: 10.1038/375159A0 |
0.322 |
|
| 1995 |
Massague J, Polyak K. Mammalian anti proliferative signals and their targets Current Opinion in Genetics & Development. 5: 91-96. PMID 7749332 DOI: 10.1016/S0959-437X(95)90059-4 |
0.403 |
|
| 1995 |
Letsou A, Arora K, Wrana JL, Simin K, Twombly V, Jamal J, Staehling-Hampton K, Hoffmann FM, Gelbart WM, Massagué J. Drosophila Dpp signaling is mediated by the punt gene product: a dual ligand-binding type II receptor of the TGF beta receptor family. Cell. 80: 899-908. PMID 7697720 DOI: 10.1016/0092-8674(95)90293-7 |
0.615 |
|
| 1995 |
Reynisdóttir I, Polyak K, Iavarone A, Massagué J. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes & Development. 9: 1831-1845. PMID 7649471 DOI: 10.1101/Gad.9.15.1831 |
0.362 |
|
| 1995 |
Wieser R, Wrana J, Massagué J. GS domain mutations that constitutively activate T beta R-I, the downstream signaling component in the TGF-beta receptor complex. The Embo Journal. 14: 2199-2208. DOI: 10.1002/J.1460-2075.1995.Tb07214.X |
0.595 |
|
| 1994 |
Wrana JL, Tran H, Attisano L, Arora K, Childs SR, Massagué J, O'Connor MB. Two distinct transmembrane serine/threonine kinases from Drosophila melanogaster form an activin receptor complex Molecular and Cellular Biology. 14: 944-950. PMID 8289834 DOI: 10.1128/Mcb.14.2.944 |
0.746 |
|
| 1994 |
Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM, Koff A. P27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest Genes and Development. 8: 9-22. PMID 8288131 DOI: 10.1101/Gad.8.1.9 |
0.339 |
|
| 1994 |
Cárcamo J, Weis FM, Ventura F, Wieser R, Wrana JL, Attisano L, Massagué J. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin. Molecular and Cellular Biology. 14: 3810-21. PMID 8196624 DOI: 10.1128/Mcb.14.6.3810 |
0.749 |
|
| 1994 |
Attisano L, Wrana JL, López-Casillas F, Massagué J. TGF-beta receptors and actions. Biochimica Et Biophysica Acta. 1222: 71-80. PMID 8186268 DOI: 10.1016/0167-4889(94)90026-4 |
0.721 |
|
| 1994 |
Nakayama H, Ichikawa F, Andres JL, Massagué J, Noda M. Dexamethasone Enhancement of Betaglycan (TGF-β Type III Receptor) Gene Expression in Osteoblast-like Cells Experimental Cell Research. 211: 301-306. PMID 8143777 DOI: 10.1006/Excr.1994.1091 |
0.389 |
|
| 1994 |
López-Casillas F, Payne H, Andres J, Massagué J. Betaglycan can act as a dual modulator of TGF-beta access to signaling receptors: mapping of ligand binding and GAG attachment sites Journal of Cell Biology. 124: 557-568. PMID 8106553 DOI: 10.1083/Jcb.124.4.557 |
0.426 |
|
| 1994 |
Wrana JL, Attisano L, Wieser R, Ventura F, Massagué J. Mechanism of activation of the TGF-beta receptor. Nature. 370: 341-7. PMID 8047140 DOI: 10.1038/370341A0 |
0.749 |
|
| 1994 |
Brummel TJ, Twombly V, Marqués G, Wrana JL, Newfeld SJ, Attisano L, Massagué J, O'Connor MB, Gelbart WM. Characterization and relationship of Dpp receptors encoded by the saxophone and thick veins genes in Drosophila. Cell. 78: 251-61. PMID 8044839 DOI: 10.1016/0092-8674(94)90295-X |
0.718 |
|
| 1994 |
Penton A, Chen Y, Staehling-Hampton K, Wrana JL, Attisano L, Szidonya J, Cassill JA, Massagué J, Hoffmann FM. Identification of two bone morphogenetic protein type I receptors in Drosophila and evidence that Brk25D is a decapentaplegic receptor. Cell. 78: 239-50. PMID 8044838 DOI: 10.1016/0092-8674(94)90294-1 |
0.727 |
|
| 1994 |
Polyak K, Lee MH, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P, Massagué J. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell. 78: 59-66. PMID 8033212 DOI: 10.1016/0092-8674(94)90572-X |
0.361 |
|
| 1994 |
Mathew S, Murty VV, Cheifetz S, George D, Massagué J, Chaganti RS. Transforming growth factor receptor gene TGFBR2 maps to human chromosome band 3p22. Genomics. 20: 114-5. PMID 8020936 DOI: 10.1006/Geno.1994.1134 |
0.318 |
|
| 1994 |
Kadin ME, Cavaille-Coll MW, Gertz R, Massague J, Cheifetz S, George D. Loss of receptors for transforming growth factor beta in human T-cell malignancies Proceedings of the National Academy of Sciences of the United States of America. 91: 6002-6006. PMID 8016105 DOI: 10.1073/Pnas.91.13.6002 |
0.433 |
|
| 1994 |
Kato JY, Matsuoka M, Polyak K, Massagué J, Sherr CJ. Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation Cell. 79: 487-496. PMID 7954814 DOI: 10.1016/0092-8674(94)90257-7 |
0.305 |
|
| 1994 |
Ventura F, Doody J, Liu F, Wrana J, Massagué J. Reconstitution and transphosphorylation of TGF-beta receptor complexes. The Embo Journal. 13: 5581-5589. DOI: 10.1002/J.1460-2075.1994.Tb06895.X |
0.559 |
|
| 1993 |
Koff A, Ohtsuki M, Polyak K, Roberts JM, Massagué J. Negative regulation of G1 in mammalian cells: Inhibition of cyclin E-dependent kinase by TGF-β Science. 260. PMID 8475385 DOI: 10.1126/Science.8475385 |
0.361 |
|
| 1993 |
Childs SR, Wrana JL, Arora K, Attisano L, O'Connor MB, Massagué J. Identification of a Drosophila activin receptor Proceedings of the National Academy of Sciences of the United States of America. 90: 9475-9479. PMID 8415726 DOI: 10.1073/Pnas.90.20.9475 |
0.735 |
|
| 1993 |
López-Casillas F, Wrana JL, Massagué J. Betaglycan presents ligand to the TGF beta signaling receptor. Cell. 73: 1435-44. PMID 8391934 DOI: 10.1016/0092-8674(93)90368-Z |
0.618 |
|
| 1993 |
Bellón T, Corbí A, Lastres P, Calés C, Cebrián M, Vera S, Cheifetz S, Massague J, Letarte M, Bernabéu C. Identification and expression of two forms of the human transforming growth factor-beta-binding protein endoglin with distinct cytoplasmic regions. European Journal of Immunology. 23: 2340-5. PMID 8370410 DOI: 10.1002/Eji.1830230943 |
0.395 |
|
| 1993 |
Wieser R, Attisano L, Wrana JL, Massagué J. Signaling activity of transforming growth factor beta type II receptors lacking specific domains in the cytoplasmic region. Molecular and Cellular Biology. 13: 7239-47. PMID 8246946 DOI: 10.1128/Mcb.13.12.7239 |
0.74 |
|
| 1993 |
Attisano L, Cárcamo J, Ventura F, Weis FM, Massagué J, Wrana JL. Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors. Cell. 75: 671-80. PMID 8242742 DOI: 10.1016/0092-8674(93)90488-C |
0.742 |
|
| 1993 |
Bosenberg MW, Massagué J. Juxtacrine cell signaling molecules Current Opinion in Cell Biology. 5: 832-838. PMID 7694603 DOI: 10.1016/0955-0674(93)90032-L |
0.355 |
|
| 1993 |
Wrana JL, Cárcamo J, Attisano L, Cheifetz S, Zentella A, López-Casillas F, Massagué J. The type II TGF-beta receptor signals diverse responses in cooperation with the type I receptor. Cold Spring Harbor Symposia On Quantitative Biology. 57: 81-6. PMID 1339707 DOI: 10.1101/Sqb.1992.057.01.011 |
0.729 |
|
| 1993 |
Wrana JL, Attisano L, Cárcamo J, Zentella A, Doody J, Laiho M, Wang XF, Massagué J. TGF beta signals through a heteromeric protein kinase receptor complex. Cell. 71: 1003-14. PMID 1333888 DOI: 10.1016/0092-8674(92)90395-S |
0.748 |
|
| 1993 |
López-Casillas F, Wrana J, Massagué J. Receptor of the third kind Trends in Cell Biology. 3: 334. DOI: 10.1016/0962-8924(93)90100-F |
0.533 |
|
| 1992 |
Ohtsuki M, Massagué J. Evidence for the involvement of protein kinase activity in transforming growth factor-beta signal transduction. Molecular and Cellular Biology. 12: 261-265. PMID 1729603 DOI: 10.1128/Mcb.12.1.261 |
0.398 |
|
| 1992 |
Massagué J, Weinberg RA. Negative regulators of growth. Current Opinion in Genetics & Development. 2: 28-32. PMID 1633423 DOI: 10.1016/S0959-437X(05)80317-X |
0.358 |
|
| 1992 |
Zentella A, Massague J. Transforming growth factor beta induces myoblast differentiation in the presence of mitogens Proceedings of the National Academy of Sciences of the United States of America. 89: 5176-5180. PMID 1594628 DOI: 10.1073/Pnas.89.11.5176 |
0.385 |
|
| 1992 |
Bosenberg MW, Pandiella A, Massagué J. The cytoplasmic carboxy-terminal amino acid specifies cleavage of membrane TGFα into soluble growth factor Cell. 71: 1157-1165. PMID 1473151 DOI: 10.1016/S0092-8674(05)80064-9 |
0.31 |
|
| 1992 |
Massagué J, Andres J, Attisano L, Cheifetz S, López-Casillas F, Ohtsuki M, Wrana JL. TGF-beta receptors. Molecular Reproduction and Development. 32: 99-104. PMID 1322148 DOI: 10.1002/Mrd.1080320204 |
0.75 |
|
| 1992 |
Massagué J. Receptors for the TGF-β family Cell. 69: 1067-1070. PMID 1319842 DOI: 10.1016/0092-8674(92)90627-O |
0.346 |
|
| 1992 |
Attisano L, Wrana JL, Cheifetz S, Massagué J. Novel activin receptors: distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors. Cell. 68: 97-108. PMID 1310075 DOI: 10.1016/0092-8674(92)90209-U |
0.712 |
|
| 1991 |
Laiho M, Rönnstrand L, Heino J, Decaprio JA, Ludlow JW, Livingston DM, Massagué J. Control of JunB and Extracellular Matrix Protein Expression by Transforming Growth Factor-β1 Is Independent of Simian Virus 40 T Antigen-Sensitive Growth-Inhibitory Events Molecular and Cellular Biology. 11: 972-978. PMID 1990295 DOI: 10.1128/Mcb.11.2.972 |
0.382 |
|
| 1991 |
Zentella A, Weis FMB, Ralph DA, Laiho M, Massagué J. Early gene responses to transforming growth factor-beta in cells lacking growth-suppressive RB function. Molecular and Cellular Biology. 11: 4952-4958. PMID 1922028 DOI: 10.1128/Mcb.11.10.4952 |
0.404 |
|
| 1991 |
López-Casillas F, Cheifetz S, Doody J, Andres JL, Lane WS, Massague J. Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-β receptor system Cell. 67: 785-795. PMID 1657406 DOI: 10.1016/0092-8674(91)90073-8 |
0.369 |
|
| 1991 |
Massagué J, Heino J, Laiho M. Mechanisms in TGF-beta action. Ciba Foundation Symposium. 157: 51-9; discussion 59-. PMID 1649037 DOI: 10.1002/9780470514061.ch4 |
0.339 |
|
| 1990 |
Anklesaria P, Teixido J, Laiho M, Pierce JH, Greenberger JS, Massague J. Cell-cell adhesion mediated by binding of membrane-anchored transforming growth factor alpha to epidermal growth factor receptors promotes cell proliferation. Proceedings of the National Academy of Sciences of the United States of America. 87: 3289-3293. PMID 2333283 DOI: 10.1073/Pnas.87.9.3289 |
0.383 |
|
| 1990 |
Massague J. The transforming growth factor-beta family. Annual Review of Cell Biology. 6: 597-641. PMID 2177343 DOI: 10.1146/Annurev.Cb.06.110190.003121 |
0.337 |
|
| 1990 |
Massagué J, Cheifetz S, Boyd FT, Andres JL. TGF-beta receptors and TGF-beta binding proteoglycans: recent progress in identifying their functional properties. Annals of the New York Academy of Sciences. 593: 59-72. PMID 2165378 DOI: 10.1111/J.1749-6632.1990.Tb16100.X |
0.39 |
|
| 1990 |
Laiho M, DeCaprio JA, Ludlow JW, Livingston DM, Massague J. Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation Cell. 62: 175-185. PMID 2163767 DOI: 10.1016/0092-8674(90)90251-9 |
0.374 |
|
| 1990 |
Boyd FT, Cheifetz S, Andres J, Laiho M, Massagué J. Transforming growth factor-beta receptors and binding proteoglycans. Journal of Cell Science. Supplement. 13: 131-8. PMID 1964683 DOI: 10.1242/Jcs.1990.Supplement_13.12 |
0.418 |
|
| 1990 |
Laiho M, Weis MB, Massagué J. Concomitant loss of transforming growth factor (TGF)-beta receptor types I and II in TGF-beta-resistant cell mutants implicates both receptor types in signal transduction. Journal of Biological Chemistry. 265: 18518-18524. DOI: 10.1016/s0021-9258(17)44782-x |
0.319 |
|
| 1989 |
Andres JL, Stanley K, Cheifetz S, Massagué J. Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-beta. Journal of Cell Biology. 109: 3137-3145. PMID 2592419 DOI: 10.1083/Jcb.109.6.3137 |
0.404 |
|
| 1989 |
Wong ST, Winchell LF, McCune BK, Earp HS, Teixido J, Massague J, Herman B, Lee DC. The TGF-α precursor expressed on the cell surface binds to the EGF receptor on adjacent cells, leading to signal transduction Cell. 56: 495-506. PMID 2464440 DOI: 10.1016/0092-8674(89)90252-3 |
0.358 |
|
| 1988 |
Luetteke NC, Michalopoulos GK, Teixidó J, Gilmore R, Massagué J, Lee DC. Characterization of high molecular weight transforming growth factor α produced by rat hepatocellular carcinoma cells Biochemistry. 27: 6487-6494. PMID 3219349 DOI: 10.1021/Bi00417A043 |
0.314 |
|
| 1988 |
Kimchi A, Wang XF, Weinberg RA, Cheifetz S, Massagué J. Absence of TGF-β receptors and growth inhibitory responses in retinoblastoma cells Science. 240: 196-199. PMID 2895499 DOI: 10.1126/Science.2895499 |
0.403 |
|
| 1987 |
Ignotz RA, Massagué J. Cell adhesion protein receptors as targets for transforming growth factor-β action Cell. 51: 189-197. PMID 3499229 DOI: 10.1016/0092-8674(87)90146-2 |
0.4 |
|
| 1987 |
Massagué J. [10] Purification of type-α transforming growth factor from transformed cells Methods in Enzymology. 146: 103-112. PMID 3479672 DOI: 10.1016/S0076-6879(87)46013-8 |
0.318 |
|
| 1987 |
Massagué J. The TGF-β family of growth and differentiation factors Cell. 49: 437-438. PMID 3471351 DOI: 10.1016/0092-8674(87)90443-0 |
0.327 |
|
| 1987 |
Massagué J. Identification of receptor proteins for type-alpha transforming growth factor. Methods in Enzymology. 146: 143-153. PMID 3316932 DOI: 10.1016/S0076-6879(87)46016-3 |
0.372 |
|
| 1987 |
Massagué J. [17] Identification of receptor for type-β transforming growth factor Methods in Enzymology. 146: 174-195. PMID 2891018 DOI: 10.1016/S0076-6879(87)46020-5 |
0.385 |
|
| 1987 |
Massagué J, Cheifetz S, Ignotz RA, Boyd FT. Multiple type-beta transforming growth factors and their receptors. Journal of Cellular Physiology. Supplement. 43-7. PMID 2890647 DOI: 10.1002/Jcp.1041330409 |
0.424 |
|
| 1987 |
Ohta M, Greenberger JS, Anklesaria P, Bassols A, Massagué J. Two forms of transforming growth factor-β distinguished by multipotential haematopoietic progenitor cells Nature. 329: 539-541. PMID 2889143 DOI: 10.1038/329539A0 |
0.366 |
|
| 1987 |
Cheifetz S, Weatherbee JA, Tsang MLS, Anderson JK, Mole JE, Lucas R, Massagué J. The transforming growth factor-β system, a complex pattern of cross-reactive ligands and receptors Cell. 48: 409-415. PMID 2879635 DOI: 10.1016/0092-8674(87)90192-9 |
0.351 |
|
| 1986 |
Centrella M, Massagué J, Canalis E. Human Platelet-Derived Transforming Growth Factor-βStimulates Parameters of Bone Growth in Fetal Rat Calvariae Endocrinology. 119: 2306-2312. PMID 3464414 DOI: 10.1210/Endo-119-5-2306 |
0.309 |
|
| 1986 |
Massague J, Cheifetz S, Endo T, Nadal-Ginard B. Type beta transforming growth factor is an inhibitor of myogenic differentiation. Proceedings of the National Academy of Sciences of the United States of America. 83: 8206-8210. PMID 3022285 DOI: 10.1073/Pnas.83.21.8206 |
0.382 |
|
| 1986 |
Ignotz RA, Kelly B, Davis RJ, Massagué J. Biologically active precursor for transforming growth factor type alpha, released by retrovirally transformed cells. Proceedings of the National Academy of Sciences of the United States of America. 83: 6307-11. PMID 3018723 DOI: 10.1073/Pnas.83.17.6307 |
0.507 |
|
| 1986 |
Massagué J, Kelly B. Internalization of transforming growth factor‐β and its receptor in BALB/c 3T3 fibroblasts Journal of Cellular Physiology. 128: 216-222. PMID 2874147 DOI: 10.1002/Jcp.1041280212 |
0.405 |
|
| 1985 |
Ignotz RA, Massagué J. Type beta transforming growth factor controls the adipogenic differentiation of 3T3 fibroblasts Proceedings of the National Academy of Sciences of the United States of America. 82: 8530-8534. PMID 3001708 DOI: 10.1073/Pnas.82.24.8530 |
0.391 |
|
| 1985 |
Massagué J. Transforming growth factor-beta modulates the high-affinity receptors for epidermal growth factor and transforming growth factor-alpha. Journal of Cell Biology. 100: 1508-1514. PMID 2985623 DOI: 10.1083/Jcb.100.5.1508 |
0.423 |
|
| 1985 |
Davis R, Like B, Massagué J. Modulation of type alpha transforming growth factor receptors by a phorbol ester tumor promoter. Journal of Cellular Biochemistry. 27: 23-30. PMID 2984222 DOI: 10.1002/Jcb.240270104 |
0.551 |
|
| 1985 |
Massagué J. The transforming growth factors Trends in Biochemical Sciences. 10: 237-240. DOI: 10.1016/0968-0004(85)90141-0 |
0.377 |
|
| 1985 |
Massagué J, Czech MP. [14] Affinity cross-linking of receptors for insulin and the insulin-like growth factors I and II Methods in Enzymology. 109: 179-187. DOI: 10.1016/0076-6879(85)09084-X |
0.553 |
|
| 1984 |
Borland K, Mita M, Oppenheimer CL, Blinderman LA, Massague J, Hall PF, Czech MP. The actions of insulin-like growth factors I and II on cultured Sertoli cells. Endocrinology. 114: 240-6. PMID 6360662 DOI: 10.1210/Endo-114-1-240 |
0.542 |
|
| 1984 |
Czech MP, Massagué J, Seals JR, Yu K. CHAPTER 4 – Mechanisms of Biological Signaling by the Insulin Receptor Biochemical Actions of Hormones. 93-125. DOI: 10.1016/B978-0-12-452811-6.50009-8 |
0.54 |
|
| 1983 |
Massague J, Freidenberg GF, Olefsky JM, Czech MP. Parallel decreases in the expression of receptors for insulin and insulin-like growth factor I in a mutant human fibroblast line Diabetes. 32: 541-544. PMID 6313454 DOI: 10.2337/Diab.32.6.541 |
0.546 |
|
| 1983 |
Massague J, Buxser S, Johnson GL, Czech MP. Affinity labeling of a nerve growth factor receptor component on rat pheochromocytoma (PC12) cells. Biochimica Et Biophysica Acta. 693: 205-12. PMID 6295482 DOI: 10.1016/0005-2736(82)90488-6 |
0.517 |
|
| 1982 |
Massague J, Czech MP, Iwata K, DeLarco JE, Todaro GJ. Affinity labeling of a transforming growth factor receptor that does not interact with epidermal growth factor. Proceedings of the National Academy of Sciences of the United States of America. 79: 6822-6. PMID 6294655 DOI: 10.1073/Pnas.79.22.6822 |
0.574 |
|
| 1981 |
Czech MP, Massague J, Pilch PF. The insulin receptor: structural features Trends in Biochemical Sciences. 6: 222-225. DOI: 10.1016/0968-0004(81)90081-5 |
0.665 |
|
| 1980 |
Czech MP, Massague J, Pilch PF, Carter-Su C. Structural features of the insulin effector system: Relation to hexose transport activation Annals of the New York Academy of Sciences. 282-291. PMID 7011146 DOI: 10.1111/J.1749-6632.1980.Tb15401.X |
0.712 |
|
| 1980 |
Massague J, Pilch PF, Czech MP. Electrophoretic resolution of three major insulin receptor structures with unique subunit stoichiometries Proceedings of the National Academy of Sciences of the United States of America. 77: 7137-7141. PMID 6938960 DOI: 10.1073/Pnas.77.12.7137 |
0.657 |
|
| Show low-probability matches. |
